BR0314388A - Combinações de atorvastatina e antagonistas de receptores adrenérgicos alfa1 - Google Patents

Combinações de atorvastatina e antagonistas de receptores adrenérgicos alfa1

Info

Publication number
BR0314388A
BR0314388A BR0314388-0A BR0314388A BR0314388A BR 0314388 A BR0314388 A BR 0314388A BR 0314388 A BR0314388 A BR 0314388A BR 0314388 A BR0314388 A BR 0314388A
Authority
BR
Brazil
Prior art keywords
combinations
atorvastatin
receptor antagonists
adrenergic receptor
alpha1 adrenergic
Prior art date
Application number
BR0314388-0A
Other languages
English (en)
Inventor
Nicholas Pullen
Richard James Thurlow
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0314388A publication Critical patent/BR0314388A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

"COMBINAçõES DE ATORVASTATINA E ANTAGONISTAS DE RECEPTORES ADRENéRGICOS ALFA~ 1~". A presente invenção refere-se a combinações de atorvastatina e antagonistas de receptores adrenérgicos <244>~ 1~, o uso de tais combinações no tratamento de hiperplasia prostática benigna (BPH), métodos de tratamento de BPH usando tais combinações e medicamentos contendo tais combinações.
BR0314388-0A 2002-09-17 2003-09-05 Combinações de atorvastatina e antagonistas de receptores adrenérgicos alfa1 BR0314388A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221579.6A GB0221579D0 (en) 2002-09-17 2002-09-17 Combinations of atorvastatin and, adrenergic receptor antagonists
PCT/IB2003/003940 WO2004026300A1 (en) 2002-09-17 2003-09-05 COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
BR0314388A true BR0314388A (pt) 2005-07-19

Family

ID=9944250

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314388-0A BR0314388A (pt) 2002-09-17 2003-09-05 Combinações de atorvastatina e antagonistas de receptores adrenérgicos alfa1

Country Status (10)

Country Link
EP (1) EP1542677A1 (pt)
CN (1) CN1681492A (pt)
AU (1) AU2003263420A1 (pt)
BR (1) BR0314388A (pt)
CA (1) CA2498894A1 (pt)
GB (1) GB0221579D0 (pt)
PL (1) PL374656A1 (pt)
TW (1) TW200407123A (pt)
WO (1) WO2004026300A1 (pt)
ZA (1) ZA200502225B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100418529C (zh) * 2006-06-30 2008-09-17 南京美瑞制药有限公司 萘哌地尔在制备促进泌尿系统结石排出的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238011B (it) * 1989-12-13 1993-06-21 Pulitzer Italiana Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
US6534537B2 (en) * 2000-01-07 2003-03-18 Kenneth Weisman Use of HMG-COA reductase inhibitors to prevent and treat BPH
GB0206033D0 (en) * 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
WO2004026300A1 (en) 2004-04-01
AU2003263420A1 (en) 2004-04-08
CA2498894A1 (en) 2004-04-01
CN1681492A (zh) 2005-10-12
TW200407123A (en) 2004-05-16
EP1542677A1 (en) 2005-06-22
GB0221579D0 (en) 2002-10-23
PL374656A1 (en) 2005-10-31
ZA200502225B (en) 2006-02-22

Similar Documents

Publication Publication Date Title
DE69940063D1 (de) Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
ID30445A (id) Metoda dan komposisi yang menggunakan norsisaprida (+) dalam gabungan dengan inhibitor pompa proton atau antagonis reseptor h2
BR0010061A (pt) Tratamento de fibrose por antagonista de il-13 e cadeias de receptor il-13
DE60210760D1 (de) Verwendung von nk-1-rezeptorantagonisten gegen benigne prostatahyperplasie
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
IS2012B (is) Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
HK1051324A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity.
SE9702773D0 (sv) Novel compounds
BRPI0417343A (pt) antagonistas do receptor muscarìnico m3 de acetilcolina
TR200002896T2 (tr) Kalsilitik Bileşimler
YU13301A (sh) Muskarinski agonisti i antagonisti
ATE424194T1 (de) Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson
AU2001285318A1 (en) Use of an aldosterone receptor antagonist to improve cognitive function
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
BR0307903A (pt) derivados de arilsulfona
HUP9700660A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása a prosztata jóindulatú hyperpláziájának megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
BRPI0415281A (pt) antagonistas de receptor de acetilcolina muscarìnico
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
EA200401137A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
BR0314388A (pt) Combinações de atorvastatina e antagonistas de receptores adrenérgicos alfa1
HUP0100781A2 (hu) A jóindulatú prosztata hiperplázia kezelésére alkalmas szubsztituált piridino aril piperazin-származékok és a vegyületeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]